Phytoceutica, Inc.

New Haven, CT 06511

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $1.22MM
First Award Date 09/15/02
Most Recent Award Date 09/01/05

Key Personnel

Last Name Name Awards Contact
Van Eyndhoven Winfried G Van Eyndhoven 2
Tilton Robert F Tilton 1
Liu Shwu-Huey Liu 1
Marathe Rajendra Marathe 2

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/05 - 08/31/06

DESCRIPTION (provided by applicant): Developing appropriate quality control metrics for botanical drugs represents a major challenge for the acceptance of botanical drugs by the FDA and, consequently, the scientific and medical communities. Recent improvements in analytical chemical methods allow for the acquisition and examination of high resol...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/05 - 08/31/06

DESCRIPTION (provided by applicant): Developing appropriate quality control metrics for botanical drugs represents a major challenge for the acceptance of botanical drugs by the FDA and, consequently, the scientific and medical communities. Recent improvements in analytical chemical methods allow for the acquisition and examination of high resol...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 08/31/05

DESCRIPTION (provided by applicant): Developing appropriate quality control metrics for botanical drugs represents a major challenge for the acceptance of botanical drugs by the FDA and, consequently, the scientific and medical communities. Recent improvements in analytical chemical methods allow for the acquisition and examination of high resol...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/04 - 02/28/05

DESCRIPTION (provided by applicant): A growing concern in the fight against cancer is the increase of liver cancer. Hepatocellular carcinoma is the most common primary cancer of the liver with an incidence rate of 30 per 100,000 in the Far East and a growing problem in the USA with approximately 13,000 new cases annually. The causes of liver ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/03 - 11/30/04

Botanical extracts are multicomponent drugs that require detailed chemical fingerprint analysis as the first critical step in assessing overall material quality. High-resolution capillary liquid chromatography (LC), coupled with ultra high resolution mass spectrometry (MS), offers a sensitive method to detect and identify a large number of diver...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/02 - 03/15/03

DESCRIPTION (provided by applicant): The FDA's recently established guidelines for the approval of prescription botanical drugs focuses on botanical drug safety, efficacy and product consistency. While safety and efficacy can be addressed in well designed clinical trials, defining metrics to measure product consistency of the complex collection ...